HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Ahlers Selected Research

HBOC 201 (Hemopure)

1/2009Resuscitation with the hemoglobin-based oxygen carrier, HBOC-201, in a swine model of severe uncontrolled hemorrhage and traumatic brain injury.
6/2008Innate immune response after resuscitation with hemoglobin-based oxygen carrier and recombinant factor VIIA in uncontrolled hemorrhagic shock in a swine model.
11/2007Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care.
11/2006Vasoactivity of bovine polymerized hemoglobin (HBOC-201) in swine with traumatic hemorrhagic shock with and without brain injury.
1/2006Immune effects of resuscitation with HBOC-201, a hemoglobin-based oxygen carrier, in swine with moderately severe hemorrhagic shock from controlled hemorrhage.
9/2005A hemoglobin-based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus hetastarch (HEX) in a moderate severity hemorrhagic shock swine model with delayed evacuation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Ahlers Research Topics

Disease

7Hemorrhagic Shock
06/2008 - 09/2005
4Hemorrhage
01/2009 - 01/2006
2Inflammation (Inflammations)
01/2020 - 06/2008
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2009 - 11/2006
2Hypotension (Low Blood Pressure)
11/2006 - 09/2005
2Tachycardia (Tachyarrhythmias)
11/2006 - 09/2005
2Soft Tissue Injuries (Soft Tissue Injury)
01/2006 - 09/2005
1Tinnitus
01/2020
1Hearing Loss (Hearing Impairment)
01/2020
1Wounds and Injuries (Trauma)
07/2010
1Crush Injuries
06/2008
1Brain Injuries (Brain Injury)
11/2006
1Necrosis
05/2006

Drug/Important Bio-Agent (IBA)

8Hemoglobins (Hemoglobin)IBA
01/2009 - 09/2005
7Oxygen (Dioxygen)IBA
01/2009 - 09/2005
6HBOC 201 (Hemopure)IBA
01/2009 - 09/2005
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2020
1Biological ProductsIBA
07/2010
1Biomarkers (Surrogate Marker)IBA
07/2010
1SolutionsIBA
01/2009
1Glial Fibrillary Acidic ProteinIBA
01/2009
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2009
1Blood Substitutes (Artificial Blood)IBA
06/2008
1Hemostatics (Antihemorrhagics)IBA
06/2008
1recombinant FVIIa (rFVIIa)FDA Link
06/2008
1EnzymesIBA
05/2006
1Creatine Kinase (Creatine Phosphokinase)IBA
05/2006
1MB Form Creatine KinaseIBA
05/2006
1Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link
09/2005

Therapy/Procedure

8Resuscitation
01/2009 - 09/2005
1Extracorporeal Shockwave Therapy
07/2010
1Catheters
11/2007